Bacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in Tanzania

Bacteraemia is a leading cause of morbidity in sickle cell anaemia (SCA), but information from studies in Africa is limited. We evaluated 890 admissions from 648 SCA patients at a tertiary hospital in Tanzania. Bacteraemia was present in 43 admissions (4·8%); isolates included Staphylococcus aureus (12/43; 28%), non‐Typhi Salmonella (9/43; 21%), Streptococcus pneumoniae (3/43; 7%) and Salmonella Typhi (2/43; 5%). Compared to SCA patients without bacteraemia, SCA patients with bacteraemia had significantly lower haemoglobin [71 g/l vs. 62 g/l, odds ratio 0·72 (95% confidence interval 0·56–0·91), P < 0·01]. Further exploration is needed of the relationship between anaemia and bacterial infections in SCA in Africa.

[1]  G. Meintjes,et al.  The value of blood culture audits at peripheral hospitals. , 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[2]  F. Kirkham,et al.  Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania , 2011, PloS one.

[3]  O. Levine,et al.  Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[4]  K. Marsh,et al.  Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control study , 2009, The Lancet.

[5]  S. Obaro.  Pneumococcal infections and sickle cell disease in Africa: does absence of evidence imply evidence of absence? , 2009, Archives of Disease in Childhood.

[6]  W. Schaffner,et al.  Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  G. Serjeant,et al.  Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? , 2006, Archives of Disease in Childhood.

[8]  I. Hambleton,et al.  Significance of fever in Jamaican patients with homozygous sickle cell disease , 2001, Archives of disease in childhood.

[9]  J. Knight-Madden,et al.  Invasive pneumococcal disease in homozygous sickle cell disease: Jamaican experience 1973-1997. , 2001, The Journal of pediatrics.

[10]  G. Serjeant,et al.  Improved survival in homozygous sickle cell disease: lessons from a cohort study , 1995, BMJ.

[11]  S. Leikin,et al.  Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. , 1989, Pediatrics.

[12]  J. Verter,et al.  Bacteremia in sickle hemoglobinopathies. , 1986, The Journal of pediatrics.

[13]  E Vichinsky,et al.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. , 1986, The New England journal of medicine.

[14]  T B Boulton,et al.  The short report. , 1982, Annals of the Royal College of Surgeons of England.